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Introduction
Identifi  ed by their unique position between the myofi  ber basal 
lamina and the overlying plasmalemma (Mauro, 1961; Bischoff, 
1994), satellite cells have been the object of intensive study for 
the past several decades, owing to their central role in muscle 
repair. More recently, several markers, including transcription 
factors such as Pax7 and Foxk1/myocite nuclear factor and cell 
surface markers such as c-Met/scatter factor receptor, syndecan 
3 and 4, and M-cadherin, have been shown to be expressed in 
quiescent satellite cells, which allows for easy immunological 
identifi  cation (Holterman and Rudnicki, 2005).
In normal resting adult skeletal muscle, satellite cells are 
found in a mitotically quiescent state but can be induced to enter 
the cell cycle by weight bearing, trauma, and specifi  c disease 
states. Activated satellite cells give rise to a transient amplifying 
population of myogenic precursor cells that undergo several 
rounds of division before undergoing terminal differentiation 
and fusing with existing fi  bers or forming new multinucleated 
fi  bers (Charge and Rudnicki, 2004). Furthermore, satellite cells 
also possess the ability to undergo self-renewal, effectively re-
populating the quiescent satellite cell compartment after activa-
tion (Zammit et al., 2004; Collins et al., 2005; Kuang et al., 
2007). Based on several observations, including different prolif-
erative capacities and variability in expression of specifi  c mark-
ers such as CD34 and Myf-5, it has been suggested that satellite 
cells are a heterogeneous population (Schultz, 1996; Beauchamp 
et al., 2000). Recent work from our laboratory has indicated that 
these differences likely refl  ect the hierarchical relationship 
between stem cells and committed cells within the satellite cell 
compartment (Kuang et al., 2007).
Despite our ability to identify quiescent satellite cells in 
resting muscle, much remains to be determined regarding the 
molecular mechanisms governing the activation of satellite cells 
and repopulation of the quiescent pool. Studies demonstrate 
that hepatocyte growth factor/scatter factor, the ligand for the 
c-Met receptor tyrosine kinase, plays a role in satellite cell activa-
tion or proliferation (Jennische et al., 1993; Tatsumi et al., 1998, 
2001, 2006). In addition, research suggests that nitric oxide 
plays a functional role in the release of hepatocyte growth factor/
scatter factor from the extracellular matrix, which implicates 
nitric oxide in satellite cell activation (Anderson, 2000; Tatsumi 
et al., 2002, 2006; Wozniak and Anderson, 2007).
Recent work also demonstrates that Notch activation oc-
curs simultaneously with satellite cell activation both in vitro 
and in vivo (Conboy and Rando, 2002). The activation of the 
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Notch signaling pathway corresponds with the entry of satel-
lite cells into a highly proliferative phase, during which the 
myogenic regulatory factors MyoD and Myf5 are activated 
(Cornelison and Wold, 1997). Furthermore, it has been demon-
strated that inhibition of Notch signaling by the Notch inhibitor 
Numb results in the terminal differentiation of committed myo-
genic precursors (Conboy and Rando, 2002). Downstream ef-
fectors of Notch signaling such as RBP-J and Stra13 appear to 
play crucial roles in mediating Notch signaling in activated 
satellite cells (Sun et al., 2007; Vasyutina et al., 2007). Differ-
ential expression of components of the Notch signaling path-
way has been demonstrated within the satellite cell compartment, 
supporting the notion that heterogeneity within this popula-
tion refl  ects its hierarchical nature (Conboy et al., 2003, 2005; 
Kuang et al., 2007).
In this study we characterize Megf10, initially cloned in 
representational difference analysis (RDA) studies designed to 
identify genes that functioned in the activation and maintenance 
of the satellite cell compartment (Seale et al., 2004). Megf10 
is the mouse homologue of human MEGF10, a multiple EGF 
  repeat–containing protein that localizes to the plasma membrane 
(Hamon et al., 2006; Suzuki and Nakayama, 2007). We reveal a 
novel role for Megf10 in regulating the proliferation and differ-
entiation of mouse skeletal muscle satellite cells. Our experi-
ments indicate that Megf10 activates Notch signaling to suppress 
progression of the differentiation program of sublaminar satel-
lite cells and sustain their self-renewal.
Results
Isolation of full-length Megf10
The RDA clone MDp67 (Seale et al., 2004) was used as a probe 
to screen a λ-phage mouse skeletal muscle cDNA library for a 
full-length cDNA. Two positive plaques with identical overlap-
ping sequences were isolated, revealing MDp67 to be the mouse 
homologue of human MEGF10 with >94% identity at the amino 
acid level. These two sequences are also similar to probable ortho-
logues CED-1 (Caenorhabditis elegans) and Draper (Drosophila 
melanogaster; Zhou et al., 2001; Freeman et al., 2003).
Megf10 is expressed in adult skeletal 
muscle and proliferating myogenic 
precursors
To defi  ne the expression pattern of Megf10 during the differen-
tiation of wild-type and MyoD
−/− primary myoblasts we performed 
quantitative PCR. Our results demonstrate down-regulation of 
Megf10 upon serum withdrawal in wild-type myoblasts. Prolif-
erating myoblasts were found to express 6.4-fold (P = 0.035) 
more Megf10 than terminally differentiated myotubes (Fig. 1 A). 
MyoD
−/− myoblasts, which fail to undergo terminal differentia-
tion after serum withdrawal, maintained Megf10 expression 
throughout the times examined (Fig. 1 A). Furthermore, our re-
sults demonstrated a 1.4-fold (P = 0.05) higher expression of 
Megf10 in MyoD
−/− myoblasts as compared with wild-type myo-
blasts maintained under the same growth conditions, and a much 
more pronounced 8.2-fold (P = 0.004) difference in expression 
5 d after serum withdrawal.
Figure 1.  Megf10 is expressed in proliferating myoblasts and resting 
adult skeletal muscle. (A) Quantitative PCR was performed on samples 
from wild-type and MyoD
−/− primary myoblasts cultured under growth (Gr) 
or differentiation (D1–D5) conditions. Samples were normalized to GAPDH 
and then to wild-type D5, which was set to a baseline expression of 1. 
Megf10 expression is down-regulated in wild-type myoblasts after serum 
withdrawal, whereas MyoD
−/− myoblasts maintain Megf10 expression 
after serum withdrawal (n = 3). Error bars represent SEM. (B) Quantitative 
PCR demonstrating the relative expression of Megf10 in mouse tissues. 
All samples were normalized to GAPDH, and the lowest expressing tissue 
(liver) was set to a baseline expression of 1. High levels of Megf10 ex-
pression are detected in the brain and in regenerating (3 d after ctx injec-
tion) skeletal muscle (n = 3). Error bars represent SEM. Br, brain; H, heart; 
K, kidney; Li, liver; Lu, lung; Sk, skeletal muscle; SkRg, regenerating skeletal 
muscle; Sp, spleen. (C) Quantitative PCR showing the relative up-regulation 
of Pax7 and Megf10 gene expression levels during activation of satellite 
cells, RNA samples were extracted from freshly isolated FACS-sorted 
α7integrin
+, CD31/Sca1/CD45
− satellite cells (Quiescent) and in vitro–
cultured myoblasts (Activated; n  = 3). Error bars represent SEM. 
(D) In situ hybridization was performed with Megf10 antisense riboprobe 
on tibialis anterior muscle from 2-mo-old mice. Transcripts are located in ﬁ  ber-
associated cells in a position relative to satellite cells (arrowheads).REGULATION OF MYOGENIC PROGRESSION BY MEGF10 • HOLTERMAN ET AL. 913
To determine if Megf10 is expressed in a tissue-specifi  c 
manner or is ubiquitously expressed throughout the organism, 
we performed quantitative PCR on RNA samples isolated from 
a variety of tissues. Very low levels of Megf10 expression were 
detected in the majority of sample examined, including in rest-
ing skeletal muscle. However, high levels of Megf10 expression 
were detected in the brain and in regenerating skeletal muscle 
3 d after cardiotoxin injection, a pattern similar to that observed 
for human MEGF10 (available at GenBank/EMBL/DDBJ 
under accession no. AB058676; http://www.kazusa.or.jp/huge/
gfpage/KIAA1780/; Nagase et al., 2001; Fig. 1 B). To further 
address the issue of Megf10 up-regulation during regeneration, 
we FACS-sorted satellite cells from the limb muscles of 8-wk-old 
wild-type mice using the same protocol as described in Kuang 
et al. (2007). Purifi  ed cells are α7integrin
+, CD31
−/Sca1
−/CD45
−, 
and 94% positive for Pax7 expression. Quantitative PCR on 
cDNA prepared from freshly isolated satellite cells and sat-
ellite cells cultured in vitro for 3 d revealed that Megf10 ex-
pression was up-regulated over 100-fold in activated satellite 
cells (Fig. 1 C).
To further verify the expression of Megf10 in adult skele-
tal muscle, we performed in situ hybridizations on frozen sec-
tions from tibialis anterior muscles of 2-mo-old wild-type adult 
mice using a digoxigenin (DIG)-labeled antisense probe to 
Megf10. The results clearly demonstrated Megf10 expression in 
cells located along the periphery of muscle fi  bers, which is con-
sistent with expression in satellite cells (Fig. 1 D). Expression 
was detected in 5–7% of cells within resting muscle. These re-
sults verify that Megf10 is expressed in resting adult skeletal 
muscle in a position and relative abundance consistent with qui-
escent satellite cells.
Megf10 is expressed in quiescent and 
activated satellite cells
To analyze expression of Megf10 protein in satellite cells, we 
generated rabbit polyclonal antisera that recognized the car-
boxy-terminal 290 aa of Megf10. Frozen sections of tibialis 
anterior muscle from 2-mo-old mice were costained with anti-
bodies reactive to Megf10 and Syndecan-4 (Syn4), a known 
marker of quiescent satellite cells (Cornelison et al., 2001). 
Approximately 80% (147/185) of cells in a sublaminar satellite 
position that expressed Syn4 also expressed detectable levels of 
Megf10 (Fig. 2 A).
Individual myofi  bers were isolated together with their as-
sociated satellite cells, immediately fi  xed, and immunostained 
for Megf10, Pax7, and M-cadherin or Syn4. Approximately 
80% (193/245) of Pax7- and M-cadherin–expressing quiescent 
satellite cells also expressed Megf10 (Fig. 2 B). Importantly, 
Megf10 was only expressed in cells that expressed Pax7 and 
was never detected in cells that did not express Pax7, verifying 
that Megf10 expression is restricted to quiescent satellite cells in 
resting adult skeletal muscle.
To investigate the pattern of Megf10 expression during 
myogenic activation, myofi  bers were cultured for 2 to 3 d in 
suspension, fi  xed and stained with a mix of antibody against Pax7, 
MyoD, and myogenin, which altogether marks the entire acti-
vated satellite cell population, and counterstained with Megf10. 
Virtually all (99.5%, 1,050/1,056) activated satellite cells stained 
positive for Megf10 (Fig. 2 D).
Megf10 was originally cloned from MyoD
−/− primary myo-
blasts that express higher levels of Megf10 and Myf5 than wild-
type myoblasts (Fig. 1 B). Therefore, to determine whether Megf10 
expression is associated with Myf5 expression in satellite cells, 
we stained individual myofi  bers, freshly isolated from previ-
ously characterized Myf5-Cre*ROSA-YFP mice, for expression 
of YFP, Pax7, and Megf10 (Kuang et al., 2007). Interestingly 
Megf10 expression was detectable in 71% (135/189) of Pax7
+/
YFP
+ committed progenitor cells but was not (0/11) observed 
in Pax7
+/YFP
− satellite stem cells (Fig. 2 C). When fi  bers were 
maintained in culture for 3 d before fi  xing and staining, all Pax7-
expressing activated satellite cells expressed Megf10, includ-
ing YFP
− cells (Fig. 2 E). Collectively these data suggest that 
although Megf10 may be correlated with Myf5 expression in a 
subset of satellite cells, Myf5 expression is not absolutely re-
quired for Megf10 expression.
Megf10 represses myogenic differentiation
To explore the biological function of Megf10 in myogenic cells, 
we infected 10T1/2 fi  broblasts, primary myoblasts, and C2C12 
myoblasts with a retrovirus designed to express a full-length 
HA-tagged Megf10. Notably, we were unable to obtain viable 
primary myoblasts that overexpressed Megf10 after retroviral 
infection. In contrast, C2C12 myoblasts and 10T1/2 fi  broblasts 
overexpressing Megf10 were readily obtained. To verify the 
appropriate localization of retroviral-expressed Megf10, we 
performed immunocytochemistry (Fig. 3 B) and cellular frac-
tionation on protein isolated from the cytoplasmic, plasma mem-
brane, nuclear membrane, and nuclear compartments (Fig. 3 A). 
Western analysis of the fractions demonstrated that retrovirally 
expressed Megf10 localized to the plasma membrane, as well as 
to the cytoplasm of infected cells (Fig. 3 A). These results are 
consistent with recent publications demonstrating plasma mem-
brane localization of MEGF10 (Hamon et al., 2006; Suzuki and 
Nakayama, 2007).
C2C12 myoblasts overexpressing Megf10 were found to 
proliferate at a higher rate than empty vector controls, with a cal-
culated 2.5-h decrease in their doubling time (P = 0.012; Fig. 3 C). 
TUNEL assays failed to demonstrate a signifi  cant change in the 
rate of apoptosis between Megf10-overexpressing cells (0.59 ± 
0.21%) and empty vector controls (0.69 ± 0.17%) or un-infected 
cells (0.64 ± 0.18%; n = 3; P = 0.44). Importantly, forced ex-
pression of Megf10 in 10T1/2 fi  broblasts did not alter their growth 
rate (unpublished data), suggesting that the effect of Megf10 
on cell cycle progression is muscle specifi  c.
We observed that Megf10 expression was markedly down-
regulated during myoblast differentiation (Fig. 1 A). Therefore, 
we asked whether or not sustained expression of Megf10 after 
serum withdrawal would have an effect on terminal differenti-
ation. Myoblasts overexpressing Megf10 showed a dramatic 
decrease in terminal differentiation, as determined by immuno-
cytochemistry (Fig. 4 A), and expressed markedly lower levels 
of myosin heavy chains (MyHC) as determined by Western 
blotting (Fig. 4 B). After 5 d in low-serum conditions, >80% 
(1,613/1,930) of empty-vector control cells had fused to form JCB • VOLUME 179 • NUMBER 5 • 2007  914
multinucleated MyHC-expressing cells (three or more nuclei/
MyHC-positive body). In contrast, of the 15% (220/1,510) 
of cells overexpressing Megf10 that had undergone terminal 
differentiation, the majority ( 50%) remained mononuclear 
(Fig. 4 C). Together these data strongly support the notion that 
ectopic Megf10 expression strongly inhibits myoblast differen-
tiation and fusion (Fig. 4 C).
To further assess the terminal differentiation of these cells, 
we performed BrdU incorporation experiments. Under growth 
conditions, similar percentages of control and experimental cells 
incorporated BrdU (Fig. 5 A). 24 h after serum withdrawal, 25% 
(715/2,860) of control cells continued to incorporate BrdU, 
likely a result of a fi  nal round of cell division before terminal dif-
ferentiation (Clegg et al., 1987). In contrast, only 5% (120/2,640) of 
Figure 2.  Megf10 is expressed in quiescent and activated satellite cells. (A) Immunohistochemistry on frozen sections of tibialis anterior muscles from 2-mo-old 
mice revealed that Megf10 was coexpressed with syndecan 4 in resting skeletal muscle. Arrowheads point to double-positive cells. Bar, 10 μm. (B) Indi-
vidual myoﬁ  bers isolated from the EDL muscle of adult mice were costained for Megf10, Pax7, and syndecan 4 or M-cadherin. Megf10 expression was 
limited to cells that also expressed Pax7 and syndecan 4 or M-cadherin (arrowheads), demonstrating that Megf10 expression is limited to quiescent satellite 
cells in resting skeletal muscle. Bar, 10 μm. (C) Individual ﬁ  bers from the EDL muscle of Myf5-Cre*ROSA-YFP reporter mice were isolated, freshly ﬁ  xed, and 
stained for YFP, Pax7, and Megf10 expression. Megf10 expression was detected in Pax7
+/YFP
+ quiescent satellite cells but never in Pax7
+/YFP
− quiescent 
satellite cells. Arrow points to a Pax7
+/YFP
−/Megf10
− satellite cell. (D) Myoﬁ  bers were cultured for 3 d and stained for Pax7, MyoD, and myogenin in the 
same color to label all satellite cells. Counterstaining with the Megf10 antibody demonstrated that all (99.5%; n > 1,000) activated satellite cells express 
Megf10. Bar, 50 μm. (E) The presence of a Pax7
+/YFP
+/Megf10
+ progenitor cell (arrowhead) and a Pax7
+/YFP
−/Megf10
− stem cell (arrow) on the same 
ﬁ  ber after isolation. After 3 d in culture, both Pax7
+/YFP
− (arrow) and Pax7
+/YFP
+ (arrowhead) proliferating cells express Megf10. Bars, 50 μm.REGULATION OF MYOGENIC PROGRESSION BY MEGF10 • HOLTERMAN ET AL. 915
Megf10-overexpressing cells continued to incorporate BrdU 
at 24 h after serum withdrawal. 48 h after serum withdrawal, 
<5% of cells in both control and experimental populations in-
corporated BrdU, and this proportion did not change at later 
times. When myoblasts ectopically expressing Megf10 were ex-
posed to low-serum conditions for 5 d and then restimulated 
with growth media for 24 h, 35% (632/1,355) of Megf10-
overexpressing cells reentered the cell cycle as demonstrated by 
their ability to incorporate BrdU (Fig. 5 B). In contrast, <10% 
(136/1,420) of uninfected myocytes reentered the cell cycle af-
ter serum stimulation, most likely because of the presence of 
undifferentiated reserve cells present after induction of differ-
entiation of C2C12 cells (Yoshida et al., 1998). These data indi-
cate that expression of Megf10 markedly inhibits myogenic 
differentiation under low-serum conditions. Moreover, infected 
myoblasts enter a reversible quiescent state rather than under-
going terminal differentiation.
Megf10 regulates key effectors of the 
myogenic program
To investigate the molecular basis for the change in growth 
kinetics and differentiation capacity of cells overexpressing 
Megf10, we examined the expression of key regulators of myo-
genic function. Strikingly, C2C12 cells overexpressing Megf10 
showed a dramatic down-regulation of MyoD and Pax7 proteins 
(Fig. 6 A). In addition, Western analysis revealed similarly de-
creased levels of Desmin and E-box–binding protein (unpub-
lished data). In contrast, the level of Myf5 protein was increased. 
Examination of protein levels during differentiation revealed a 
failure of Megf10-overexpressing myoblasts to up-regulate myo-
genin (Fig. 6 A) and MyHC (Fig. 4 B) during differentiation.
Quantitative PCR analysis was performed to determine if 
the changes in Myf5, MyoD, and Pax7 protein levels refl  ected 
changes in the level of mRNA. Importantly, Myf5 mRNA was 
up-regulated and Pax7 mRNA was down-regulated to a similar 
degree as the changes in protein levels. In contrast, no signifi  -
cant change was detected in MyoD mRNA levels (Fig. 6 B). 
The results suggest a posttranscriptional down-regulation of 
MyoD protein levels in Megf10-expressing myoblasts.
Megf10 regulates the balance between 
proliferation and differentiation within the 
satellite cell compartment
Having demonstrated that Megf10 is expressed in all activated 
satellite cells and that forced expression of Megf10 inhibited 
differentiation of myogenic cells, we set out to determine whether 
Megf10 regulated the proliferative potential of activated satel-
lite cells. Individual fi  bers were isolated from extensor digito-
rum longus (EDL) muscles of 8-wk-old mice and transfected 
after 24 h with Cy3-labeled siRNA against Megf10. siRNA-Cy3 
incorporation by satellite cells was monitored 24 h after trans-
fection, with an effi  ciency ranging from 51 to 79% (unpublished 
data). Fibers were maintained in culture for 72 h (48 h after 
transfection) and then stained for Pax7 and Megf10 expression. 
Loss of Megf10 immunostaining in the context of si-Megf10 
transfections validated the effi  ciency of the knockdown (Fig. 7 A). 
Figure 3.  Overexpression of Megf10 enhances proliferation of 
myogenic cells. (A) C2C12 myoblasts were infected with Megf10. 
Western blot with α-HA reveals Megf10 expression in the plasma 
membrane and cytoplasmic fractions. Fraction purity was exam-
ined by blotting for integrin α4 (plasma membrane), Grb2 (cyto-
plasm), Lamin A (nuclear membrane), and TBP (nuclear). Whole 
cell extract was used as a positive control. (B) Immunocytochemis-
try on infected cells demonstrated cytoplasmic and potential plasma 
membrane localization of Megf10 in infected cells but not controls. 
Bar, 10 μm. (C) C2C12 cells infected with Megf10 or empty vec-
tor puro controls were counted at either 24, 48, or 72 h after 
plating (n = 9). Error bars represent SEM.JCB • VOLUME 179 • NUMBER 5 • 2007  916
A 30% decrease (n > 900; P = 0.05) was observed in the mean 
number of activated satellite cells at the surface of isolated fi  bers 
(Fig. 7 B). Furthermore, a 62% (n > 400; P = 0.009) reduction 
was observed in the number of Pax7
+/MyoD
− transient self-
renewing cells (Fig. 7 C). Interestingly, the ratio of YFP
− stem 
cells to YFP
+ progenitor cells was unaltered (n > 500), suggest-
ing a proportionate reduction in the number of cells in both pop-
ulations (Fig. 7 D).
To determine if the reduction in the number of activated 
satellite cells was caused by premature differentiation, we ana-
lyzed Pax7 and myogenin protein expression in satellite cells on 
transfected fibers with si-scrambled and si-Megf10, at a time 
Figure 4.  Overexpression of Megf10 inhibits differentiation of myogenic 
cells. (A) C2C12 cells infected with Megf10 or empty vector puro controls 
were stained with α-MyHC. Cells overexpressing Megf10 displayed a dra-
matic decrease in differentiation as compared with controls. (B) Western 
blots reveal a dramatic decrease in MyHC expression at 5 d after serum 
withdrawal in cells overexpressing Megf10. (C) The number of nuclei per 
MyHC-positive body was examined and plotted to demonstrate that al-
though <5% of MyHC-positive control cells remained mononuclear, 50% of 
MyHC-positive Megf10 cells failed to fuse to form multinucleated myo-
tubes (n = 3). Error bars represent SEM.
Figure 5.  Megf10 stimulates quiescence after serum withdrawal. (A) C2C12 
myoblasts infected with Megf10 or empty vector puro control were main-
tained in growth media or differentiated for 1 to 5 d. Cells were stained for 
BrdU incorporation. Approximately 30% of cells incorporate BrdU under 
growth conditions. Within 24 h of serum withdrawal, only 8% of Megf10-
expressing cells incorporate BrdU, indicating withdrawal from the cell cycle, 
whereas 25% of control cells incorporate BrdU. A large percentage of cells 
expressing Megf10 that were subjected to low serum were able to reenter 
the cell cycle, whereas the majority of control cells had terminally differenti-
ated (n = 3). Bar, 100 m. (B) Histogram demonstrating the number of cells 
that incorporated BrdU during a 30-min pulse after 120 h of differentiation 
and 24 h of restimulation (n = 3). Error bars represent SEM.REGULATION OF MYOGENIC PROGRESSION BY MEGF10 • HOLTERMAN ET AL. 917
before the cell-depleting effect of Megf10 knockdown takes 
place. We chose to fi  x and stain transfected fi  bers at 60 h in cul-
ture in vitro (36 h after transfection). At this time, activated sat-
ellite cells on fi  bers had gone through three doublings, and the 
mean number of activated cells per fi  ber was similar (si-scram-
bled: 51.25 ± 3.37 cells/fi  ber; si-Megf10: 50.24 ± 4.77 cells/
fi  ber). As expected, we saw a major increase in the proportion of 
myogenin-expressing cells (3.15-fold increase; n > 2,000; P = 
0.0036) after transfection of si-Megf10 as compared with si-
scrambled. These results demonstrate that knockdown of Megf10 
expression results in precocious differentiation of activated 
satellite cells (Fig. 8 A).
Transfection of primary myoblasts with siRNA against 
Megf10 resulted in a 0.5-fold (P < 10
−5) decrease in Megf10 
expression and a corresponding 1.8-fold (P < 10
−3) increase in 
myogenin expression and a 2.5-fold (P < 10
−4) increase in 
MyHC expression, as determined by quantitative PCR, verify-
ing increased differentiation upon Megf10 silencing (Fig. 8 B). 
Interestingly,  Pax7,  MyoD, and Myf5 expression were also 
down-regulated after siMegf10 transfection as a direct effect of 
Megf10 knockdown forcing myogenic differentiation. These re-
sults further demonstrate the ability of Megf10 to regulate the 
proliferative potential of sublaminar satellite cells.
Megf10 impinges on the Notch signaling 
pathway
Recent work has indicated that the extracellular domain of 
JEDI, a Megf10 family member, is capable of modulating Notch 
signaling in a manner similar to members of the Jagged/Serrate/
Delta family of Notch ligands (Krivtsov et al., 2007). We there-
fore examined expression levels of Notch signaling components 
after Megf10 knockdown. Because the loss of Megf10 expression 
leads to premature differentiation of primary myoblasts, we 
used MyoD
−/− myoblasts, which cannot differentiate and more 
closely resemble satellite cells (Megeney et al., 1996; Sabourin 
et al., 1999; Seale et al., 2004). This allowed us to investigate 
the effects of Megf10 down-regulation on Notch signaling in a 
cellular context where the down-regulation of Notch signaling 
induced by differentiation cannot occur.
Cells were transiently transfected with a cocktail of three 
different plasmids containing unique short hairpin RNAs  (shRNAs) 
against Megf10. Transfection effi  ciency was found to be 30% 
using β-galactosidase as a reporter. After transfection with 
the shRNA, Megf10 expression was determined using quantita-
tive real-time PCR. We detected a 0.56-fold (P = 0.012) reduc-
tion in overall levels of Megf10 expression in cells transfected 
with Megf10 shRNA as compared with a nonsilencing control 
(Fig. 8 C). We did not detect signifi  cant changes in the levels of 
Pax7 or Pax3 expression after Megf10 knockdown; however, we 
did note a 1.5-fold (P = 0.034) increase in Myf5 expression 
(Fig. 8 C). Notably, we observed down-regulation of Notch re-
ceptors Notch 1 (0.56-fold; P = 0.001), Notch 2 (0.64-fold; P = 
0.027), and Notch 3 (0.41-fold; P = 0.018), as well as down-
regulation of Notch downstream effector Hes 1 (0.52-fold; P = 
0.046) after Megf10 knockdown. No signifi  cant difference was 
observed in the expression of Notch ligands Delta-like 1, Delta-
like 4, or Jagged 1 (Fig. 6 D). These data support the notion that 
the extracellular domain of Megf10, similar to the correspond-
ing domain of DSL proteins, activates Notch signaling. Collec-
tively, these experiments suggest that Megf10 plays a key role 
in controlling the expression of key regulators of myogenic 
commitment and differentiation.
Discussion
In recent years, several new markers of quiescent satellite cells 
have been identifi  ed, providing insight into the origins of these 
cells as well as the mechanisms by which they affect muscle re-
generation. Using RDA, we have identified several potential 
satellite cell markers, including Megf10, a multiple EGF re-
peat–containing transmembrane protein (Seale et al., 2004). 
Although orthologues of Megf10 (CED-1 and Draper) have been 
previously identifi  ed and shown to function in engulfment of 
apoptotic cells during neurogenesis, a role for Megf10 in satel-
lite cell function has not been previously described (Zhou et al., 
2001; Freeman et al., 2003).
Megf10, although highly expressed in the brain, is also 
expressed in resting adult skeletal muscle, as determined by in 
situ hybridization, and its expression is up-regulated in response 
to injury as determined by quantitative PCR. Our immunohisto-
chemical analysis on sections from tibialis anterior muscles and 
individual fi  bers isolated from EDL muscle clearly demonstrate 
that the expression of Megf10 is strictly limited to the majority 
Figure 6.  Overexpression of Megf10 alters the levels of key myogenic 
proteins. (A) Western blot of protein extracts from Megf10-overexpressing 
cells and empty vector puro controls. Myf5 levels are elevated in Megf10-
overexpressing cells, whereas MyoD and Pax7 are down-regulated under 
growth conditions. Cells overexpressing Megf10 fail to up-regulate myo-
genin during differentiation. (B) Quantitative PCR analysis reveals that al-
though Myf5 and Pax7 RNA levels are altered in Megf10-expressing cells, 
alterations in MyoD are occurring mainly at the protein level (*, P < 0.02). 
Transcript levels are normalized to GAPDH and control levels are set to 
1 (n = 3). Error bars represent SEM.JCB • VOLUME 179 • NUMBER 5 • 2007  918
of quiescent satellite cells in resting muscle. Although we only 
detected Megf10 in Myf5-Cre-YFP
+/Pax7
+ satellite cells, it is 
possible that Megf10 expression level in the quiescent Myf5-
Cre-YFP
−/Pax7
+ satellite stem cell population is below detect-
able levels in our assays. Interestingly, we observed Megf10 
expression in all satellite cells of individual fi  bers after activa-
tion, suggesting that all satellite cells up-regulate Megf10 upon 
activation. This is in agreement with our quantitative PCR anal-
ysis, which demonstrated signifi  cant up- regulation of Megf10 
in activated satellite cells.
Our results demonstrate that overexpression of Megf10 
in myogenic cells in vitro results in enhanced proliferation. 
In wild-type myoblasts, Megf10 expression is down-regulated 
during terminal differentiation. In cells modifi  ed to overexpress 
Megf10, expression is maintained after serum withdrawal and a 
dramatic inhibition of differentiation is observed. Importantly, 
cells overexpressing Megf10 exit the cell cycle within 24 h of 
serum withdrawal, as determined by BrdU incorporation, but 
maintain the ability to reenter the cell cycle through serum 
stimulation. These results suggest that maintained Megf10 ex-
pression allows cells to return to a quiescent state where they 
can respond to subsequent stimulation. Collectively, these data 
implicate Megf10 as being an important regulator of satellite 
cell function by suppressing the progression of the differentia-
tion program of sublaminar satellite cells and thus enforcing 
self-renewal. It has recently been demonstrated that in the ab-
sence of Myf5, the transient activating population is dramati-
cally compromised in adult skeletal muscle, and in response to 
injury, activated satellite cells undergo precocious differentia-
tion in viable Myf5
−/− mice (Ustanina et al., 2007). Thus, it 
would appear that although MyoD expression is required 
for the appropriate differentiation of activated satellite cells, 
Myf5 functions in the expansion and proliferation of these cells. 
Interestingly, cells overexpressing Megf10 express elevated 
levels of Myf5 and decreased levels of MyoD, much like 
MyoD
−/− myoblasts, which show a propensity for proliferation 
and self-renewal rather than differentiation (Megeney et al., 
1996; Sabourin et al., 1999). Although there is an increase in 
the level of Myf5 RNA in these cells, it has not been deter-
mined if this is a direct effect of Megf10 overexpression stimu-
lating Myf5 transcription. Alternatively, repression of the Myf5 
locus may be relieved because of the absence of MyoD protein 
Figure 7.  Megf10 regulates satellite cell activation and proliferation. (A) Individual ﬁ  bers isolated from EDL muscles were transfected with Megf10 siRNA, 
cultured for 3 d, and stained for Pax7 and Megf10. siRNA knockdown induces a loss of Megf10 protein expression by the majority of the activated satellite 
cells (n = 3). Bar, 50 μm. (B) Histograms depicting individual counts of the total numbers of activated satellite cells (labeled with Pax7 and MyoD/myogenin) 
on ﬁ  bers transfected with Megf10 siRNA. The mean number of myogenic cells per ﬁ  ber is reduced by a mean of 30% as compared with scrambled siRNA 
controls (n = 3). (C) Knockdown of Megf10 dramatically reduces the number of self-renewing progenitors (Pax7
+/MyoD
−) from 19 to 7% and respec-
tively increases the number of Pax7
+/MyoD
+ cells (n = 3; **, P = 0.008). Error bars represent SEM. (D) Although the number of activated progenitor cells is 
reduced, the overall ratio of stem cell (YFP
−) to progenitor cell (YFP
+) remains unchanged (n = 3). Error bars represent SEM.REGULATION OF MYOGENIC PROGRESSION BY MEGF10 • HOLTERMAN ET AL. 919
(Megeney et al., 1996). We believe the latter to be the case, as 
knockdown of Megf10 expression in MyoD
−/− myoblasts does 
not result in down-regulation of Myf5. In fact, Myf5 transcript 
levels increase upon Megf10 silencing. Interestingly, we have 
previously demonstrated that Myf5 levels are elevated at 
early time points after serum withdrawal in MyoD
−/− myoblasts 
(Sabourin et al., 1999). Based on our results, one could specu-
late that Megf10 may suppress the progression of the differentia-
tion program of sublaminar satellite cells by modulating Myf5 
and MyoD expression.
The role of Megf10 in regulating the proliferative poten-
tial of the satellite cell compartment is further supported by our 
knockdown experiments in vitro and on individual fi  bers. In vitro, 
knockdown of Megf10 resulted in precocious differentiation 
of primary myoblasts maintained under growth conditions. 
Megf10 knockdown on individual fibers resulted in a pro-
nounced decrease in the number of activated precursor cells 
because of precocious differentiation, as determined by a sig-
nifi  cant increase in the number of myogenin-expressing cells at 
60 h, a time at which the number of cells per fi  ber (si-Megf10 vs. 
si-scrambled) is not signifi  cantly different. Megf10 knockdown 
also resulted in a concomitant reduction in the number of transient 
self-renewing cells per fi  ber after 72 h in culture. Furthermore, it 
is important to note that the overall proportion of Myf5-Cre-YFP
− 
stem cells to Myf5-Cre-YFP
+ committed progenitor cells was 
unaltered, implying that loss of Megf10 expression results in 
precocious differentiation of both the stem and progenitor satel-
lite cell populations. This is not unexpected, given that after ac-
tivation all satellite cells express Megf10. These results imply a 
critical role for Megf10 in the appropriate self-renewal of the 
satellite cell compartment.
It has been well demonstrated that Notch signaling is a 
critical determinant in the progression of satellite cells toward 
myogenesis (Conboy and Rando, 2002). Satellite cell activation 
and proliferation is accompanied by an increase in expression 
of Notch receptors and Notch signaling, whereas terminal dif-
ferentiation occurs after inhibition of Notch signaling (Conboy 
and Rando, 2002). All satellite cells express Notch-1 and satel-
lite stem cells (YFP
−) express Notch-3, whereas the committed 
progenitor population (YFP
+) expresses the Notch ligand Delta-
like-1 (Kuang et al., 2007). Inhibition of Notch signaling results 
in a loss of the stem cell population and premature differentiation, 
suggesting that the Notch signaling pathway plays a crucial role 
in the self-renewal of satellite cells (Kuang et al., 2007).
Of interest is the potential interaction of Megf10 with the 
Notch signaling pathway. A recent publication demonstrates the 
ability of JEDI, a potential Megf10 family member, to regulate 
the Notch signaling pathway in a delta-like manner in hemato-
poietic cells (Krivtsov et al., 2007). Furthermore, it has been 
demonstrated that constitutive activation of Notch signaling in 
myoblasts results in enhanced proliferation and defective differ-
entiation, a phenotype that is strikingly similar to that observed 
upon overexpression of Megf10 in myoblasts (Nofziger et al., 
1999; Conboy and Rando, 2002).
Our results suggest that Megf10 regulates the proliferative 
capacity of myogenic cells, potentially via the Notch signaling 
pathway. With 30% transfection effi  ciency, we were able to re-
duce Megf10 expression 0.56-fold overall in primary MyoD
−/− 
myoblasts. This was accompanied by a reduction of Notch 
receptors’ transcripts and down-regulation of Hes1, which can 
be directly linked to the precocious differentiation observed in 
wild-type myoblasts after Megf10 knockdown, a result remi-
niscent of a loss of Notch signaling. Up-regulation of Myf5 
Figure 8.  Loss of Megf10 results in precocious differentiation. (A) EDL ﬁ  -
bers were transfected with Megf10 siRNA, cultured for 60 h, and stained 
for Pax7 and myogenin. Megf10 knockdown induces three times more 
cells to undergo precocious differentiation (n = 3; **, P = 0.004). Error 
bars represent SEM. Bar, 50 μm. (B) Quantitative PCR analysis demon-
strates up-regulation of myogenin and MyHC and down-regulation of 
Pax7, MyoD, and Myf5 in wild-type primary myoblasts in which Megf10 
has been knocked down (n = 6; *, P < 0.05; **, P < 0.01). Error bars 
represent SEM. (C) Quantitative PCR demonstrates down-regulation of 
components of the Notch signaling pathway after shRNA knockdown 
of Megf10 in MyoD
−/− primary myoblasts (n = 3; *, P < 0.05; **, 
P < 0.01). Error bars represent SEM.JCB • VOLUME 179 • NUMBER 5 • 2007  920
after Megf10 silencing in MyoD
−/− myoblasts, coupled with the 
observed decrease in Notch and Hes1 transcript levels, suggests 
that down-regulation of Megf10 allows cells to progress toward 
terminal differentiation. However, Megf10 silencing did not res-
cue the differentiation defi  cit observed in MyoD
−/− myoblasts 
(unpublished data), most likely because of the requirement for 
MyoD activity for subsequent differentiation.
It is curious that we only detected Megf10 expression in 
the committed progenitor population of quiescent satellite cells, 
which also express Delta-like-1, whereas it was up-regulated in 
all satellite cells after activation. Such heterogeneity within the 
quiescent satellite cell compartment has previously been de-
scribed for other markers such as CD34 and Myf5 as well as 
components of the Notch signaling pathway and may be indica-
tive of the hierarchical nature of the satellite cell compartment 
(Beauchamp et al., 2000; Conboy et al., 2003, 2005; Kuang et al., 
2007). Alternatively, the heterogeneity observed within the sat-
ellite cell compartment may refl  ect differences between naive 
satellite cells established during development and those that have 
been activated subsequent to their developmental establishment. 
Importantly, these concepts are not mutually exclusive.
Given the ability of Megf10 expression to alter growth 
and differentiation kinetics of myoblasts as well as the levels of 
key myogenic proteins, we hypothesize that Megf10 functions 
to maintain the satellite cell compartment. It does so by main-
taining self-renewing cells’ proliferation and by inhibiting their 
progression through the myogenic program and terminal differ-
entiation. After activation of satellite cells, Megf10 may dictate 
whether a cell continues to proliferate, returns to a quiescent state, 
or enters the myogenic program to undergo terminal differentia-
tion. This, we propose, is accomplished by modulating Notch 
signaling. Although the mechanism by which Megf10 expression 
is regulated remains to be elucidated, our fi  ndings demonstrate 
a novel and critical role for Megf10 in the regulation of satellite 
cell dynamics and maintenance.
Materials and methods
RNA isolation and real-time PCR
RNA was isolated using the RNeasy Miniprep kit (QIAGEN) and subjected 
to on column DNase digestion as per the manufacturer’s instructions. 
RT-PCR of samples was performed using the Core PCR kit (PerkinElmer) us-
ing random hexamer primers. Real-time PCR was performed as previously 
described (Ishibashi et al., 2005). Transcript levels were normalized to 
glyceraldehyde 3–phosphate dehydrogenase (GAPDH) transcript levels. 
Relative fold change in expression was calculated using the ∆∆CT method 
(CT values < 30). Primer sequences for Pax7, Pax3, Megf10, Notch1, 
Notch2, Notch3, Delta1, Jagged, and Hes were as follows; Pax7, forward, 
C  T  G  G  A  T  G  A  G  G  G  C  T  C  A  G  A  T  G  T  ; Pax7, reverse, G  G  T  T  A  G  C  T  C  C  T  G  C  C  T-
G  C  T  T  A  ; Pax3, forward, G  C  T  G  T  C  T  G  T  G  A  T  C  G  G  A  A  C  A  C  T  ; Pax3, reverse, 
C  T  C  C  A  G  C  T  T  G  T  T  T  C  C  T  C  C  A  T  C  ; Megf10, forward, A  C  T  G  G  A  G  C  C  T  T  C  T-
G  T    G  A  G  G  A  ; Megf10, reverse, A  C  A  C  T  G  G  C  A  T  T  C  T  T  G  G  G  A  A  C  ; Notch1, 
forward, G  G  T  C  G  C  A  A  C  T  G  T  G  A  G  A  G  T  G  A  ; Notch1, reverse, T  T  G  C  T  G  G  C-
A  C  A  T  T  C  A  T  T  G  A  T  ; Notch2, forward, G  C  A  G  G  A  G  C  A  G  G  A  G  G  T  G  A  T  A  G  ; 
Notch2, reverse, G  C  G  T  T  T  C  T  T  G  G  A  C  T  C  T  C  C  A  G  ; Notch3, forward, G  T  C  C-
A  G  A  G  G  C  C  A  A  G  A  G  A  C  T  G  ; Notch3, reverse, C A  G  A  A  G  G  A  G  G  C  C  A  G  C  A  T-
A  A  G  ; Delta1, forward, C  C  G  G  C  T  G  A  A  G  C  T  A  C  A  G  A  A  A  C  ; Delta1, reverse, 
G  A  A  A  G  T  C  C  G  C  C  T  T  C  T  T  G  T  T  G  ; Jagged1, forward, G  G  A  T  G  A  T  G  G  G  A  A  C  C-
C  T  G  T  C  A  A  G  ; Jagged1, reverse, T  G  T  T  T  A  T  T  T  G  T  C  C  A  G  T  T  C  G  G  G  T  G  T  ; HES1, 
forward, C  C  C  A  C  C  T  C  T  C  T  C  T  T  C  T  G  A  C  G  ; HES1, reverse, A  G  G  C  G  C  A  A  T  C-
C  A  A  T  A  T  G  A  A  C  ; MyHCF G  A  C  C  A  G  A  T  C  T  T  C  C  C  C  A  T  G  A  A  ; MyHCR T  A  A  G  G-
G  T  T  G  A  C  G  G  T  G  A  C  A  C  A  . GAPDH, MyoD, myogenin, and Myf5 primers 
were as previously described (Ishibashi et al., 2005).
FACS sorting
Satellite cells were isolated as per Kuang et al. (2007). RNA was isolated 
from freshly sorted α7integrin
+, CD31
−/Sca1
−/CD45
− cells, or the same 
cells maintained in culture for 3 d as previously described.
In situ hybridization
In situ hybridizations were performed on 8-μm cryosections of mouse tibia-
lis anterior muscles from 2-mo-old mice according to previously described 
procedures (Braissant and Wahli, 1998). Sense and antisense in situ 
probes were synthesized from the original RDA product using DIG labeling 
mix (Roche) with SP6 or T7 RNA polymerase (Roche). Alkaline phospha-
tase–conjugated anti-DIG antibody (Roche) followed by reaction with 
BCIP/NBT (Roche) was used to detect hybridized cRNA probes.
Phage library screen
A commercially prepared mouse embryonic day 10.5 Lambda cDNA 
phage library (Stratagene) was plated at 5 × 10
4 plaque forming units per 
plate. A total of 5 × 10
5 plaques were plated and lifted as per the manu-
facturer’s instructions. Plaques were screened using a radiolabeled probe 
generated using the original MDp67 RDA clone. Positive plaques were 
cored and eluted as per the manufacturer’s instructions, and secondary 
and tertiary screens were performed at 10
3 and 10
2 plaque forming units 
per plate, respectively. The two positive clones were sequenced and com-
pared/aligned using DNAStar software (DNAstar Inc.).
Retroviral production and infection
Retrovirus was generated using a modiﬁ  ed version of the three-plasmid HIT 
system (provided by V. Sartorelli, National Institutes of Health, Bethesda, 
MD) as previously described (Soneoka et al., 1995; Ishibashi et al., 2005). 
For retroviral infection, C2C12 cells were seeded at 10
5 cells per 10-cm 
plate. 8 h after plating, cells were incubated with retrovirus for 12 h with 
8 μg/ml polybrene. Cells were then washed twice with PBS and maintained 
in growth media for 24 h before the addition of antibiotics for selection.
Protein isolation and cellular fractionation
Protein was isolated as previously described (Perry et al., 2001). For cellu-
lar fractions, cells were washed twice in ice-cold PBS-fused vesicles and 
scrapped off plates in 1 ml PBS-fused vesicles. Cells were pelleted, resus-
pended in 5 ml of ice-cold hypotonic buffer (10 mM Hepes, pH 8.0, 15 mM 
KCl, 2 mM MgCl2, and 0.1 mM EDTA), incubated for 5 min, and lysed using 
a dounce homogenizer on ice. Supernatant was then centrifuged at 65,000 
rpm at 4°C for 1 h using NVT100 rotor in an ultracentrifuge (Beckman 
Coulter). Supernatant was collected and the membrane pellet resuspended 
in NP-40 lysis buffer with protease inhibitors (1 mM DTT, 1 mM PMSF, 
10 mg/ml pepstatin A, aprotinin, leupeptin, and 1 mM sodium vanadate). 
The nuclear pellet was washed once in buffer A and then incubated on ice 
for 20 min in buffer C. Nuclear lysates were centrifuged and supernatants 
were diluted with buffer D with protease inhibitors.
Western blotting
Western analysis was performed as previously described (Sabourin et al., 
1999). Antibodies used for these studies were as follows: α-MyoD (C-20; 
Santa Cruz Biotechnology, Inc.), α-Myf5 (C-20; Santa Cruz Biotechnology, 
Inc.), α-Pax7 (PAX7; Developmental Studies Hybridoma Bank), α-HA (HA7; 
Sigma-Aldrich), α-myogenin (F5D [Developmental Studies Hybridoma Bank] 
or M225 [Santa Cruz Biotechnology, Inc.]), and α-MyHC (MF20; Develop-
mental Studies Hybridoma Bank). α-Megf10 antibody was generated in 
rabbits against a GST fusion protein containing the carboxy-terminal 290 aa of 
Megf10 (Washington Biotechnology).
BrdU incorporation
C2C12 myoblasts were maintained in growth media (DME supplemented with 
10% FBS) or differentiation media (DME supplemented with 2% horse serum). 
Cells were pulsed for 30 min with 30 mM BrdU and stained using the BrdU 
In situ Detection kit (BD Biosciences) as per the manufacturer’s instructions.
Fiber isolation and immunohistochemistry
Tibialis anterior muscles were isolated from 2-mo-old mice. Muscles were 
incubated overnight through a series of sucrose solutions (4, 15, and 30%). 
After overnight incubation in 30% sucrose/PBS, the muscles were embed-
ded in optimal cutting temperature and ﬂ  ash frozen in liquid nitrogen. Sec-
tions were cut at 8 μm using a cryostat (Leica). Sections were incubated 
with primary antibody overnight (α-Megf10, 1:200 [Washington Biotech-
nology] or α–syndecan-4, 1:200 [gift from B. Olwin, University of Colorado, 
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secondaries were used for visualization. Images were obtained at room 
temperature using a microscope (Axioskop; Carl Zeiss, Inc.), 20× NA 0.50 
plan-Neoﬂ  uar (ω/0.17; Carl Zeiss, Inc.) or 40× NA 0.75 plan-Neoﬂ  uar 
(ω/0.17; Carl Zeiss, Inc.) objective, and camera (SPOT; Diagnostic Instru-
ments, Inc.). Images were captured using SPOT 3.5.5 software (Diagnostic 
Instruments, Inc.) and were processed with Photoshop (Adobe).
Fibers were isolated as previously described (Kuang et al., 2006), 
and either directly ﬁ  xed or grown for 2–3 d in Ham’s F10 media supple-
mented with 20% FBS, penicillin/streptomycin, and 2.5 ng/μl of basic 
FGF (Ham’s complete) on horse serum–coated culture dishes. Individual 
ﬁ  bers were ﬁ  xed, permeabilized, and incubated with primary antibodies 
at the following dilutions: α-Megf10, 1:50; α-Pax7, 1:10; α–M-cadherin, 1:200; 
α–syndecan-4, 1:200; α-MyoD, 1:50; α–myogenin F5D, 1:10; and 
α-myogenin M225,1:50. Secondary antibodies used were Alexa 488, 
Alexa 568, and Alexa 647 conjugated to speciﬁ  c IgG types (Invitrogen) 
that matched the primary antibodies.
Images were obtained using a microscope (Axioplan2; Carl Zeiss, 
Inc.), a 20× NA 0.75 plan Apochromat (ω/0.17; Carl Zeiss, Inc.) objective, 
and a digital camera (Axiocam; Carl Zeiss, Inc.). Digital images were cap-
tured using Axiovision (Carl Zeiss, Inc.) and were processed with Photoshop.
Megf10 siRNA and shRNA knockdown
EDL ﬁ  bers were plated in media without antibiotics, and transfection was car-
ried at 24 h after dissection using Lipofectamine 2000 reagent (Invitrogen) as 
per the manufacturer’s instructions. Three different siRNA duplexes were used 
at the ﬁ  nal concentration of 20 nM each. Fibers were refed in fresh media 
with antibiotics on the next morning and ﬁ  xed after 60–72 h of culture.
MyoD
−/− primary myoblasts were grown on 10-cm collagen-coated 
dishes in Ham’s F10 media supplemented with 20% FBS, penicillin/
streptomycin, and 2.5 ng/μl of basic FGF (Ham’s Complete). Cells were 
refed 3 h before transfection with serum-free media and transfected with a 
mix of three different shRNA plasmids (OpenBiosystems) for a total of 4 μg 
of plasmid DNA, using ArrestIn transfection reagent (OpenBiosystems) as 
per the manufacturer’s instructions. Cells were washed and re-fed with 
Ham’s complete media 6 h after transfections. RNA was harvested 48 h 
after transfection.
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